Replay available

Baxter International Inc. (BAX) Q1 2026 Earnings Call

Baxter International Inc. (NYSE: BAX) Q1 2026 earnings conference call, held 2026-04-30. Replay captured from the company's public earnings webcast.

Thu, April 30, 2026 at 8:30 AMendedReplay
Baxter International Inc. (BAX) Q1 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Kevin Moran

Vice President, Investor Relations

Andrew Heider

President and Chief Executive Officer

Anita Zielinski

Interim Chief Financial Officer, Chief Accounting Officer and Controller

Robbie Marcus

Analyst, J.P. Morgan

David Roman

Analyst, Goldman Sachs

Larry Beigelson

Analyst, Wells Fargo Securities

Fajay Kumar

Analyst, Evercore ISI

Matt Nixick

Analyst, Barclays

Joanne Wunsch

Analyst, Citi

Jason Bedford

Analyst, Raymond James

Replay transcript excerpt

Good morning, ladies and gentlemen, and welcome to Baxter International's First Quarter twenty twenty six Earnings Call. Your lines will remain in a listen only mode until the question and answer segment of today's call. As a reminder, this call is being recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter's permission. If you have any objections, please disconnect at this time. I would now like to turn the call over to Mr. Kevin Moran, Vice President, Investor Relations at Baxter International. Mr. Moran, you may begin. Good morning, and welcome. Today, we'll discuss Baxter's first quarter results along with our financial outlook for the full year 2026. This morning, a press release was issued with our preliminary earnings results and reiterated outlook. The press release and investor presentation are available on the Investors section of the Baxter website. Joining me today are Andrew Heider, President and Chief Executive Officer and Anita Zelensky, Interim Chief Financial Officer, Chief Accounting Officer and Controller. During the call, we will be making forward looking statements, including comments regarding our reiterated financial outlook for the full year 2026 and the anticipated drivers of the second quarter and second half twenty twenty six performance the anticipated impact of various regulatory and operational matters, including ones related to our infusion pump platform and ongoing supply chain challenges and commentary regarding the global macroeconomic environment, including estimated impacts of tariffs and broader inflationary pressures. Forward looking statements involve risks and uncertainties, which could cause our actual results to differ materially from our current expectations. Please refer to toda...

More from Baxter International Inc.